HELLUMS RHONDA LYNETTE enters ARATANA THERAPEUTICS, INC. with 26.50K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 26.50K | Direct |
| Total | 26.50K | 26.50K direct |
Stock Option (Right to Buy)
DirectUnderlying shares
25K
Shares owned
N/A
Exercise price
22.91
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
2.65K
Shares owned
N/A
Exercise price
17.18
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
6.70K
Shares owned
N/A
Exercise price
3.14
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
15.10K
Shares owned
N/A
Exercise price
4.22
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
14.70K
Shares owned
N/A
Exercise price
4.83
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying shares
4.10K
Shares owned
N/A
Exercise price
8.02
Expiration
—
Exercise window
—
Underlying
68.25K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 22.91 | — | — | 25K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 17.18 | — | — | 2.65K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 3.14 | — | — | 6.70K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 4.22 | — | — | 15.10K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 4.83 | — | — | 14.70K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 8.02 | — | — | 4.10K | N/A |
| Total | 68.25K | 0.00 | ||||